《SMW,2月7日,2019-Novel Coronavirus (2019-nCoV): estimating the case fatality rate – a word of caution》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-02-08
  • 2019-Novel Coronavirus (2019-nCoV): estimating the case fatality rate – a word of caution

    DOI: https://doi.org/10.4414/smw.2020.20203

    Publication Date: 07.02.2020

    Swiss Med Wkly. 2020;150:w20203

    Battegay Manuel, Kuehl Richard, Tschudin-Sutter Sarah, Hirsch Hans H., Widmer Andreas F., Neher Richard A.

    Estimating and predicting the extent and lethality of the 2019-Novel Coronavirus (2019-nCoV) outbreak, originating in Wuhan/China is obviously challenging, reflected by many controversial statements and reports. Unsurpassed to date, an ever-increasing flow of information, immediately available and accessible online, has allowed the description of this emerging epidemic in real-time [1]. The first patients were reported in Wuhan on December 31st 2019 [2]. Only a few days later, Chinese researchers identified the etiologic agent now known as the 2019-nCoV and published the viral sequence [3]. New data on the virus, its characteristics and epidemiology become available 24/7 and are often shared via informal platforms and media [4]. Yet, key questions remain largely unanswered.

  • 原文来源:https://smw.ch/article/doi/smw.2020.20203
相关报告
  • 《MedRixv,2月12日,Caution on Kidney Dysfunctions of 2019-nCoV Patients》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-02-13
    • Caution on Kidney Dysfunctions of 2019-nCoV Patients Anti-2019-nCoV Volunteers, Zhen Li, Ming Wu, Jie Guo, Jiwei Yao, Xiang Liao, Siji Song, Min Han, Jiali Li, Guangjie Duan, Yuanxiu Zhou, Xiaojun Wu, Zhansong Zhou, Taojiao Wang, Ming Hu, Xianxiang Chen, Yu Fu, Chong Lei, Hailong Dong, Yi Zhou, Hongbo Jia, Xiaowei Chen, Junan Yan doi: https://doi.org/10.1101/2020.02.08.20021212 Abstract Until 24:00 of February 7th 2020, 31774 laboratory-confirmed cases of novel coronavirus (2019-nCoV) infection have been reported, including 6101 severe cases in critical conditions and 722 deaths. The critical and urgent need at this moment is to find an effective treatment strategy with available means to prevent these thousands of severe inpatients from worsening and dying. It has been recently known that the 2019-nCoV shares a common cellular mechanism with the severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Thus, we surveyed a previous retrospective case study on SARS which showed that acute renal impairment was uncommon in SARS but carried a formidably high mortality (91.7%, 33 of 36 cases). Here we report an ongoing case study on kidney functions in 59 patients infected by 2019-nCoV (including 28 diagnosed as severe cases and 3 deaths). 63% (32/51) of the patients exhibited proteinuria, indicative of renal impairment. 19% (11/59) and 27% (16/59) of the patients had an elevated level of plasma creatinine and urea nitrogen respectively. The computerized tomography (CT) scan showed radiographic abnormalities of the kidneys in 100% (27/27) of the patients. Together, these multiple lines of evidence point to the idea that renal impairment is common in 2019-nCov patients, which may be one of the major causes of the illness by the virus infection and also may contribute to multi-organ failure and death eventually. Therefore, we strongly suggest exercising a high degree of caution in monitoring the kidney functions of 2019-nCoV patients and, very importantly, that applying potential interventions including continuous renal replacement therapies (CRRT) for protecting kidney functions as early as possible, particular for those with plasma creatinine rising, is key to preventing fatality. *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.
  • 《LANCET,2月7日,Pandemic potential of 2019-nCoV》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-02-09
    • Pandemic potential of 2019-nCoV Robin Thompson Published:February 07, 2020DOI:https://doi.org/10.1016/S1473-3099(20)30068-2 An important determinant of whether or not 2019 novel coronavirus (2019-nCoV) will ultimately cause a global pandemic is its ability to become established upon its importation to a new country. Cases of 2019-nCoV infection have so far been reported in 24 countries, yet little human-to-human transmission outside of China has occurred.